Handbook

PREREQUISITE: PHA3011 and one of PHA3021, BMS3021 or BMS3031

A case study focussed on drug development is used to contextualise the Unit content

Online activities will be used to help students consolidate and apply key concepts

This unit uses a student-centered, active learning approach which aims to encourage the build-up of knowledge and understanding that is required to achieve a deeper level of learning to facilitate efficient use of knowledge

Authentic learning activities will be undertaken to build knowledge and understanding of the drug development process within industry & academia

Students will assume the role of a research & development team within a pharmaceutical company to gain an indepth understanding and appreciation of the steps in the drug discovery process

Self- and peer-marking sessions will help students develop skills to critically evaluate their own and others' work as well as engaging them in the assessment process

If you would otherwise have passed the unit but you do not achieve at least 45% of the marks available for the in-semester assessment you will receive a Hurdle Fail (NH) grade and a mark of 45 on your transcript.

If you would otherwise have passed the unit but you do not achieve at least 45% of the marks available for the end-of-semester examination you will receive a Hurdle Fail (NH) grade and a mark of 45 on your transcript.

• Applies to all offerings

• Applies to all offerings

• Applies to all offerings

Two 1-hour lectures and three hours of laboratory or self-directed learning/ tutorial per week.

Rang HP, Dale MM, Ritter JM, Flower RJ & Henderson G. Rang & Dale’s Pharmacology 8th edn, Churchill Livingstone, 2016.

Rang HP. Drug Discovery and Development: Technology in Transition 2nd edn. Churchill Livingstone, 2013.